Qritive - Revision history

C at 04:36, 27 December 2025

2025-12-27T04:36:02Z

← Older revision		Revision as of 04:36, 27 December 2025
Line 9:		Line 9:
	\|headquarters=Singapore		\|headquarters=Singapore
	}}		}}
	{{PAGENAME}} is a Singapore-based startup developing [[medical ai]] to provide clinical decision support for interpretations of pathology whole slide image scans.		{{PAGENAME}} is a Singapore-based startup developing [[medical AI]] to provide clinical decision support for interpretations of pathology whole slide image scans.

	==Technology==		==Technology==

C at 01:47, 26 December 2025

2025-12-26T01:47:13Z

← Older revision		Revision as of 01:47, 26 December 2025
Line 9:		Line 9:
	\|headquarters=Singapore		\|headquarters=Singapore
	}}		}}
	{{PAGENAME}} is a ~~COUNTRY~~-based startup developing ~~TECHNOLOGY~~ for ~~APPLICATION~~.		{{PAGENAME}} is a Singapore-based startup developing [[medical ai]] to provide clinical decision support for interpretations of pathology whole slide image scans.

	==Technology==		==Technology==
	~~Describe the underlying science~~ and ~~technology of the startup here~~. ~~Ideally, it should provide~~ a ~~layman introduction of any key differentiators~~ and/~~or novel or proprietary scientific breakthroughs being commercialised by the startup~~.		Qritive offers a suite of AI-powered diagnostic modules designed to support pathologists across a broad range of clinical applications—from cancer diagnosis and metastasis detection on Hematoxylin and Eosin stained whole-slide images to biomarker analysis on immunohistochemistry whole-slide images. Their modules are able to analyse entire whole-slide images within seconds<ref>{{Cite web \|title=Other AI Modules \|url=https://www.qritive.com/other-ai-modules \|access-date=2025-12-26 \|website=Qritive \|language=en}}</ref>.

			Qritive has developed a comprehensive image management system to streamline pathology workflows from slide viewing and case management to AI-supported diagnosis and structured reporting<ref>{{Cite web \|title=Pantheon ™ \|url=https://www.qritive.com/pantheon \|access-date=2025-12-26 \|website=Qritive \|language=en}}</ref>.

	==Traction==		==Traction==
	~~List notable customers or partnerships here~~. ~~Awards should not~~ be ~~listed here~~, ~~but under "Accolades" instead~~		The startup's diagnostic solution to support detection and grading of prostate cancer was given Class C In Vitro Diagnostic (IVD) Approval from Singapore’s Health Sciences Authority in August 2025<ref>{{Cite web \|last=Qritive \|date=2025-08-05 \|title=QAi Prostate Grade Receives Class C IVD Approval from Singapore’s Health Sciences Authority \|url=https://www.qritive.com/post/qai-prostate-grade-receives-class-c-ivd-approval-from-singapore-s-health-sciences-authority \|access-date=2025-12-26 \|website=Qritive \|language=en}}</ref> and regulatory approval from Abu Dhabi's Department of Health in July 2025<ref>{{Cite web \|last=Qritive \|date=2025-07-28 \|title=QAi Prostate Grade Receives Regulatory Approval from Abu Dhabi’s Department of Health \|url=https://www.qritive.com/post/qai-prostate-grade-receives-regulatory-approval-from-abu-dhabi-s-department-of-health \|access-date=2025-12-26 \|website=Qritive \|language=en}}</ref>.

			In August 2025, Qritive announced that their lymph node metastasis detection solution would be adopted by Dr Lal PathLabs, an Indian diagnostic provider<ref>{{Cite web \|last=Qritive \|date=2025-08-20 \|title=Dr Lal PathLabs Selects Qritive’s AI-Powered Solution to Strengthen Cancer Diagnostics \|url=https://www.qritive.com/post/dr-lal-pathlabs-selects-qritives-ai-powered-solution-to-strengthen-cancer-diagnostics \|access-date=2025-12-26 \|website=Qritive \|language=en}}</ref>.

			In September 2024, the startup announced a collaboration with Roche, to integrate their solution into Roche's digital pathology platform<ref>{{Cite web \|last=Qritive \|date=2024-09-11 \|title=Qritive Joins Forces with Roche to Redefine Global Cancer Diagnostics with AI \|url=https://www.qritive.com/post/qritive-joins-forces-with-roche-to-redefine-global-cancer-diagnostics-with-ai \|access-date=2025-12-26 \|website=Qritive \|language=en}}</ref>.

	==Accolades==		==Accolades==
	~~List awards received by~~ the startup ~~here~~.		In July 2025, the startup was selected as an awardee at the Japan Smart Healthy Aging QuickFire Challenge, an initiative by Johnson & Johnson Innovation to support breakthrough healthcare solutions focused on increasing healthy life expectancy in Japan<ref>{{Cite web \|last=Qritive \|date=2025-06-30 \|title=Qritive Recognized in Japan Smart Healthy Aging QuickFire Challenge \|url=https://www.qritive.com/post/qritive-recognized-in-japan-smart-healthy-aging-quickfire-challenge \|access-date=2025-12-26 \|website=Qritive \|language=en}}</ref>.

	==Funding==		==Funding==
	Qritive raised a $7.5 million Series A round led by [[MassMutual Ventures]] in January 2023<ref>{{Cite web \|date=2023-01-09 \|title=Healthcare AI Firm Qritive Raises $7.5M to Expand into New Markets \|url=https://apnews.com/press-release/ein-presswire-newsmatics/business-medical-technology-singapore-ein-presswire-newsmatics-boston-0a6efe37a84d2126137b725f5790f30e \|access-date=2025-12-26 \|website=AP News \|language=en}}</ref>.{{Startup/Funding history}}		Qritive raised a $7.5 million Series A round led by [[MassMutual Ventures]] in January 2023<ref>{{Cite web \|date=2023-01-09 \|title=Healthcare AI Firm Qritive Raises $7.5M to Expand into New Markets \|url=https://apnews.com/press-release/ein-presswire-newsmatics/business-medical-technology-singapore-ein-presswire-newsmatics-boston-0a6efe37a84d2126137b725f5790f30e \|access-date=2025-12-26 \|website=AP News \|language=en}}</ref>.{{Startup/Funding history}}

	~~== See also ==~~
	* List any other pages directly relevant to {{PAGENAME}}

	== References ==		== References ==
	{{Reflist}}		{{Reflist}}

C at 01:27, 26 December 2025

2025-12-26T01:27:50Z

← Older revision		Revision as of 01:27, 26 December 2025
Line 21:		Line 21:

	==Funding==		==Funding==
	~~Describe the startup's funding history here~~. ~~Include investors~~ in ~~the table below~~.{{Startup/Funding history}}		Qritive raised a $7.5 million Series A round led by [[MassMutual Ventures]] in January 2023<ref>{{Cite web \|date=2023-01-09 \|title=Healthcare AI Firm Qritive Raises $7.5M to Expand into New Markets \|url=https://apnews.com/press-release/ein-presswire-newsmatics/business-medical-technology-singapore-ein-presswire-newsmatics-boston-0a6efe37a84d2126137b725f5790f30e \|access-date=2025-12-26 \|website=AP News \|language=en}}</ref>.{{Startup/Funding history}}

	== See also ==		== See also ==

C: Created page with "{{Infobox Startup |logo=Qritive-logo.png |status=Active |website=https://www.qritive.com/ |vertical=Medtech, Artificial intelligence, Digital Health |trl=Deployment (TRL 7-8) |latest_funding=Series A |founding_year=2017 |headquarters=Singapore }} {{PAGENAME}} is a COUNTRY-based startup developing TECHNOLOGY for APPLICATION. ==Technology== Describe the underlying science and technology of the startup here. Ideally, it should provide a layman introduction of any key di..."

2025-12-26T01:24:57Z

Created page with "{{Infobox Startup |logo=Qritive-logo.png |status=Active |website=https://www.qritive.com/ |vertical=Medtech, Artificial intelligence, Digital Health |trl=Deployment (TRL 7-8) |latest_funding=Series A |founding_year=2017 |headquarters=Singapore }} {{PAGENAME}} is a COUNTRY-based startup developing TECHNOLOGY for APPLICATION. ==Technology== Describe the underlying science and technology of the startup here. Ideally, it should provide a layman introduction of any key di..."

New page

{{Infobox Startup
|logo=Qritive-logo.png
|status=Active
|website=https://www.qritive.com/
|vertical=Medtech, Artificial intelligence, Digital Health
|trl=Deployment (TRL 7-8)
|latest_funding=Series A
|founding_year=2017
|headquarters=Singapore
}}
{{PAGENAME}} is a COUNTRY-based startup developing TECHNOLOGY for APPLICATION.

==Technology==
Describe the underlying science and technology of the startup here. Ideally, it should provide a layman introduction of any key differentiators and/or novel or proprietary scientific breakthroughs being commercialised by the startup.

==Traction==
List notable customers or partnerships here. Awards should not be listed here, but under "Accolades" instead

==Accolades==
List awards received by the startup here.

==Funding==
Describe the startup's funding history here. Include investors in the table below.{{Startup/Funding history}}

== See also ==
* List any other pages directly relevant to {{PAGENAME}}

== References ==
{{Reflist}}